Richard S. Lindahl - 08 Jun 2026 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Reporting relationship
EVP, Chief Financial Officer
Issuer ticker
EBS
Reported as of
08 Jun 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Jun 2026, 15:08:23 UTC
Prior SEC filing
01 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Richard S. Lindahl

Key filing fact

Richard S. Lindahl filed Form 4 for Emergent BioSolutions Inc. (EBS) on 10 Jun 2026.

Key facts

  • This page summarizes Richard S. Lindahl's Form 4 filing for Emergent BioSolutions Inc. (EBS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Jun 2026, 15:08.

Change

  • Previous filing in this sequence was filed on 01 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001196632 Primary reporting owner

LINDAHL RICHARD S

Relationship
EVP, Chief Financial Officer
Address
300 PROFESSIONAL DRIVE, GAITHERSBURG
Signature
/s/ Richard S. Lindahl
Signature date
10 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EBS transaction

Common Stock

Tax liability

Transaction value
Shares
-3,964
Change %
-1%
Price
$8.00*
Shares after
374,083
Date
08 Jun 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .